Testing cilostazol to clear brain bleed
Part of Brain & nervous system, Heart & circulation clinical trials.
This clinical trial tests whether a medication called cilostazol can help the body reabsorb a brain bleed (intracerebral hemorrhage) more quickly. It is for adults with a small bleed in a specific part of the brain (thalamus or basal ganglia) who are otherwise in good health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 20 and 80 years old.
- Your brain bleed must be in the thalamus or basal ganglia (deep brain areas).
- The bleed must be small (less than 15 ml) and you must have been admitted to the hospital within 24 hours of your symptoms starting.
- Your blood counts, liver function, kidney function, and blood clotting must be normal.
- You must not be taking blood thinners like aspirin, clopidogrel, or warfarin when the bleed happened.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests whether celecoxib (an anti-inflammatory medicine) can improve outcomes after an intracerebral hemorrhage (a type of stroke caused by bleeding in the brain). It also studies how the medicine may help the body recover. You would need to start treatment quickly after symptoms begin and meet several safety and bleeding-control requirements.
This trial tests whether a common antiplatelet medicine can reduce the risk of future heart attacks, strokes, or blood clots in people who have had a brain bleed. It's for adults who had their first brain bleed and can start treatment within 3 months of the stroke.
This trial tests a rapid procedure to remove a blood clot in the brain after a specific type of stroke. It might help people with a moderate-sized bleed in the front part of the brain if treatment can start within 24 hours.
This trial tests a minimally invasive procedure to remove deep brain bleeds using a special puncture guided by brain imaging, combined with a clot-dissolving drug called tenecteplase. It may help reduce damage from the bleed and improve recovery.
This trial tests a non-invasive ultrasound device to help clear blood clots from the brain after a spontaneous bleed. It may be an option for people with small to medium-sized bleeds who do not need surgery.
This trial tests whether adding a drug called cilostazol to standard care (nimodipine) helps people recover better after a type of stroke caused by a bleeding brain aneurysm. It may help prevent complications like narrowing of blood vessels in the brain.
Hear when a new ICH - Intracerebral Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.